Sagar Lonial, MD
Noopur Raje, MD
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
Lyudmila Bazhenova, MD
Benjamin Levy, MD
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
Larry Anderson, MD, PhD
Thomas G. Martin, MD
State of the Union: CAR T Cell Therapy
Jacqueline Garcia, MD
David A. Sallman, MD
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Str…
Scott Kopetz, MD, PhD
Elena Elez, MD, PhD
Elizabeth Smyth, MD
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
Mark Socinski, MD
Vivek Subbiah, MD
Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC
Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive …
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
Joël Guigay, MD, PhD
Kevin J. Harrington, MD
Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities
Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Appr…
Daniel P. Petrylak, MD
Arlene O. Siefker-Radtke, MD
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or M…
Justin Gainor, MD
Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC
Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in…
Lauren Ritterhouse, MD ,PhD
Pasi Antero Jänne, MD, PhD
Kanwal Raghav, MD
The Role of HER3 Expression in Advanced Solid Tumors
Jeffrey S. Weber, MD, PhD
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melano…
Rona Yaeger, MD
Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
Johann de Bono, MD, PhD
Alicia K. Morgans, MD, MPH
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Globa…
Jay Raman, MD, FACS
Oguz Akin, MD
Robert J. Motzer, MD
Elizabeth Plimack, MD, MS
RCC Treatment Strategies in a Poor-Risk Patient
Shira Johnson, MD
Robert Vonderheide, MD
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Loading...
Stay current with the best on medical education
Learn More
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
